Litcius/Paper detail

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells

Kosuke Watari, Tomohiro Shibata, Hideaki Fujita, Ai Shinoda, Yûichi Murakami, Hideyuki Abe, Akihiko Kawahara, Hiroshi Ito, Jun Akiba, Shigeo Yoshida, Michihiko Kuwano, Mayumi Ono

2020Communications Biology38 citationsDOIOpen Access PDF

Abstract

Abstract Many diseases, including cancer, have been associated with impaired regulation of angiogenesis, of which vascular endothelial growth factor (VEGF)-A is a key regulator. Here, we test the contribution of N-myc downstream regulated gene 1 (NDRG1) to VEGF-A-induced angiogenesis in vascular endothelial cells (ECs). Ndrg1 −/− mice exhibit impaired VEGF-A-induced angiogenesis in corneas. Tumor angiogenesis induced by cancer cells that express high levels of VEGF-A was also reduced in a mouse dorsal air sac assay. Furthermore, NDRG1 deficiency in ECs prevented angiogenic sprouting from the aorta and the activation of phospholipase Cγ1 (PLCγ1) and ERK1/2 by VEGF-A without affecting the expression and function of VEGFR2. Finally, we show that NDRG1 formed a complex with PLCγ1 through its phosphorylation sites, and the inhibition of PLCγ1 dramatically suppressed VEGF-A-induced angiogenesis in the mouse cornea, suggesting an essential role of NDRG1 in VEGF-A-induced angiogenesis through PLCγ1 signaling.

Topics & Concepts

AngiogenesisVascular endothelial growth factorCell biologyNeovascularizationMAPK/ERK pathwayRegulatorCancer researchVascular endothelial growth factor ABiologyChemistrySignal transductionVEGF receptorsGeneBiochemistryMechanisms of cancer metastasisCancer Mechanisms and TherapyHippo pathway signaling and YAP/TAZ